News Chart MetaStat, Inc.

Equities

MTST

US59140A2033

Delayed OTC Markets Other stock markets 13:47:00 2023-07-27 EDT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-.--%

2018	MetaStat, Inc. Presents Positive Data Showing Inhibition of the MENA-Pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer	CI
2017	MetaStat, Inc. Appoints Renato T. Skerlj as Member of its Scientific and Clinical Advisory Board	CI

267535271564b52ab6.MXxTnbEouRpcaE3vUKMMmkhWXRaK-1Avnxtwx6QQ2ck.XjAn6JxNim8VGHyLM9Jeqzs5ZWO5i2R4yWMet8kjj_9XUR3UyWvJXgwnLg~e543ac97d28184eb96fb839363195d95